The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.
Farogh Gibraiel
Advertisement
Farogh Gibraiel is senior downstream process development specialistat Polpharma Biologics S.A., Warsaw, Poland.
Articles by Farogh Gibraiel
Advertisement
Latest Updated Articles
Advertisement
Advertisement